Top Markets
Coin of the day
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.

GeneReach Biotechnology Corp.

4171
Rang in aandelen #27717
GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes... GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes in the development, production, and commercialization of advanced nucleic acid detection technologies. The company's extensive product line features essential laboratory instrumentation, including automated nucleic acid extraction systems, prep homogenization systems, and mini centrifuges. GeneReach also provides a wide range of reagents and consumables, such as human In Vitro Diagnostic (IVD) assays, specific iiPCR reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and various research-grade reagents and supplies. Beyond its product offerings, GeneReach delivers comprehensive services. These encompass polymerase chain reaction (PCR) training programs, expert molecular diagnostic technical solutions, laboratory installation assistance, OEM/ODM contract manufacturing capabilities, and collaborative research services. Its innovative solutions cater to a diverse clientele, with applications spanning aquaculture, agriculture, food safety, human health, and the welfare of companion animals and livestock. GeneReach Biotechnology Corp. was established in 2004.
Aandeelprijs
$0.54853323
Marktkapitalisatie
$31.43M
Verandering (1 dag)
0.58%
Verandering (1 jaar)
-18.14%
Land
TW
Handel GeneReach Biotechnology Corp. (4171)

Categorie

Prijs 4171 met de marktkapitalisatie van B
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
4171
$0.54853323
Marktkapitalisatie van GeneReach Biotechnology Corp.(4171)
Marktkapitalisatie: $31.43M
Vanaf August 2026 heeft GeneReach Biotechnology Corp. een marktkapitalisatie van $31.43M. Dit maakt GeneReach Biotechnology Corp. volgens onze gegevens het 27717th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van GeneReach Biotechnology Corp. van 2012 tot 2026
4171 vergeleken met de top 5 populairste stocks
Prijs voor 4171 Aandeel B Marktkapitalisatie van B uitslagen
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$92,500.74 $31.43M
$5.301T +16,863,188.18%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$80,861.52 $31.43M
$4.634T +14,741,307.10%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$72,295.48 $31.43M
$4.143T +13,179,680.97%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$62,634.96 $31.43M
$3.589T +11,418,525.66%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$49,854.07 $31.43M
$2.857T +9,088,514.97%